Inventor · disambiguated record
Brian S. J. Blagg
Also filed as: BLAGG BRIAN · BLAGG BRIAN S · BLAGG BRIAN S J
34 granted patents·4 pending applications·501 citations·filing 2004–2025
97Inventor score
Top patents by PatentIndex Score
38 records- 0196US7608594B2Novobiocin analogues as anticancer agentsUNIV KANSAS·Filed 2005·Granted Oct 27, 2009·108 cites·34 claims
- 0295US7960353B2Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disordersUNIV KANSAS·Filed 2009·Granted Jun 14, 2011·32 cites·15 claims
- 0395US7208630B2Heat shock protein 90 inhibitorsUNIV KANSAS·Filed 2004·Granted Apr 24, 2007·46 cites·9 claims
- 0494US10882881B2C-terminal Hsp90 inhibitorsUNIV KANSAS·Filed 2020·Granted Jan 5, 2021·3 cites·20 claims
- 0594US7622451B2Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disordersUNIV KANSAS·Filed 2007·Granted Nov 24, 2009·114 cites·24 claims
- 0693US9422320B2C-terminal HSP90 inhibitorsUNIV KANSAS·Filed 2013·Granted Aug 23, 2016·23 cites·19 claims
- 0793US7811998B2Novobiocin analogues as anticancer agentsUNIV KANSAS·Filed 2009·Granted Oct 12, 2010·30 cites·18 claims
- 0892US11708319B2Biphenyl amides with modified ether groups as HSP90 inhibitors and HSP70 inducersUNIV KANSAS·Filed 2021·Granted Jul 25, 2023·2 cites·19 claims
- 0991US11390640B2C-terminal Hsp90 inhibitorsUNIV KANSAS·Filed 2020·Granted Jul 19, 2022·2 cites·21 claims
- 1091US10590157B2C-terminal HSP90 inhibitorsUNIV KANSAS·Filed 2018·Granted Mar 17, 2020·7 cites·20 claims
- 1191US10030041B2C-terminal Hsp90 inhibitorsUNIV KANSAS·Filed 2016·Granted Jul 24, 2018·9 cites·20 claims
- 1291US9056104B2Dynamic inhibitors of heat shock protein 90BLAGG BRIAN S J·Filed 2012·Granted Jun 16, 2015·11 cites·27 claims
- 1391US8212012B2Novobiocin analogues having modified sugar moietiesBLAGG BRIAN S J·Filed 2009·Granted Jul 3, 2012·26 cites·27 claims
- 1490US11098008B2Biphenyl amides with modified ether groups as Hsp90 inhibitors and Hsp70 inducersUNIV KANSAS·Filed 2020·Granted Aug 24, 2021·3 cites·19 claims
- 1590US7605288B2Heat shock protein 90 inhibitorsUNIV KANSAS·Filed 2007·Granted Oct 20, 2009·7 cites·16 claims
- 1690US2024417419A1C-terminal hsp90 inhibitorsUNIV KANSAS·Filed 2024·Application pending·0 cites
- 1787US11028041B2Second generation GRP94-selective inhibitorsUNIV KANSAS·Filed 2018·Granted Jun 8, 2021·2 cites·20 claims
- 1886US8212011B2Novobiocin analoguesBLAGG BRIAN·Filed 2009·Granted Jul 3, 2012·20 cites·31 claims
- 1985US9120774B2Novobiocin analogues having modified sugar moietiesBLAGG BRIAN S J·Filed 2010·Granted Sep 1, 2015·21 cites·22 claims
- 2084US12024536B2C-terminal HSP90 inhibitorsUNIV KANSAS·Filed 2022·Granted Jul 2, 2024·0 cites·16 claims
- 2184US10745386B2Coumarin based HSP90 inhibitors with urea and ether substituentsUNIV KANSAS·Filed 2018·Granted Aug 18, 2020·4 cites·14 claims
- 2284US10689344B2Biphenylamide derivative Hsp90 inhibitorsUNIV KANSAS·Filed 2014·Granted Jun 23, 2020·4 cites·16 claims
- 2384US10590065B2Biphenyl amides with modified ether groups as HSP90 inhibitors and HSP70 inducersUNIV KANSAS·Filed 2015·Granted Mar 17, 2020·6 cites·13 claims
- 2483US10030006B2Coumarin based Hsp90 inhibitors with urea and ether substituentsUNIV KANSAS·Filed 2014·Granted Jul 24, 2018·6 cites·17 claims
- 2581US8188306B2Heat shock protein 90 inhibitorsBLAGG BRIAN S J·Filed 2009·Granted May 29, 2012·2 cites·9 claims
- 2680US9994556B2Triazole modified coumarin and biphenyl amide-based HSP90 inhibitorsUNIV KANSAS·Filed 2015·Granted Jun 12, 2018·4 cites·20 claims
- 2780US9045434B1Compositions and methods of treatment for myocilin glaucoma by selectively inhibiting GRP94DICKEY CHAD ANTHONY·Filed 2013·Granted Jun 2, 2015·7 cites·2 claims
- 2876US2025257027A1Second generation grp94-selective inhibitorsUNIV KANSAS·Filed 2025·Application pending·0 cites
- 2974US12269798B2Second generation GRP94-selective inhibitorsUNIV KANSAS·Filed 2021·Granted Apr 8, 2025·0 cites·24 claims
- 3068US11318155B2Hsp90 activator Aha1 drives production of pathological tau aggregatesUNIV SOUTH FLORIDA·Filed 2018·Granted May 3, 2022·1 cites·12 claims
- 3168US8685966B2GRP94 inhibitorsBLAGG BRIAN S J·Filed 2012·Granted Apr 1, 2014·1 cites·13 claims
- 3267US11939291B2GRP94 selective inhibitors and uses thereofUNIV KANSAS·Filed 2021·Granted Mar 26, 2024·0 cites·20 claims
- 3362US11931373B2HSP90 activator AHA1 drives production of pathological tau aggregatesUNIV SOUTH FLORIDA·Filed 2022·Granted Mar 19, 2024·0 cites·15 claims
- 3452US10975030B2Grp94 selective inhibitors and uses thereofUNIV KANSAS·Filed 2017·Granted Apr 13, 2021·0 cites·14 claims
- 3547US12030867B2Hsp90β selective inhibitorsUNIV NOTRE DAME DU LAC·Filed 2019·Granted Jul 9, 2024·0 cites·29 claims
- 3638US2021030719A1Grp94 inhibitors to treat steroid-induced ocular hypertensions and glaucomasUNIV SOUTH FLORIDA·Filed 2019·Application pending·0 cites
- 3737US2011082098A1Novobiocin analogues and treatment of polycystic kidney diseaseUNIV KANSAS·Filed 2010·Application pending·0 cites
- 3836US10927076B2HSP90B N-terminal isoform-selective inhibitorsUNIV KANSAS·Filed 2018·Granted Feb 23, 2021·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Brian S. J. Blagg files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →